# The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection

> **NCT02408146** · NA · UNKNOWN · sponsor: **First Affiliated Hospital of Harbin Medical University** · enrollment: 80 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **PROCEDURE:** conventional intravenous infusion pump
- **DRUG:** parecoxib
- **PROCEDURE:** intravenous infusion pump of patient-controlled analgesia
- **DRUG:** fentanyl citrate+ ondansetron hydrochloride + normal saline
- **DRUG:** celecoxib

## Key facts

- **NCT ID:** NCT02408146
- **Lead sponsor:** First Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2015-07
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2015-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408146, "The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02408146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*